BHIC Bioscience Health Innovations Inc.

Fundamentals / CIK 0001784440 / USD

Bioscience Health Innovations Inc. reported $4.33M in revenue and a net loss of $799K for the trailing twelve months ended September 30, 2026 (down 14.3% year over year), with a 54.4% gross margin and a -17.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BHIC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2020 to 2025), reported in USD.

$5.63M$2.82M$0-$719KFY 2020 Revenue: $0FY 2020 Net Income: -$7.7K2020FY 2021 Revenue: $0FY 2021 Net Income: -$26K2021FY 2022 Revenue: $0FY 2022 Net Income: -$83K2022FY 2022 Revenue: $69KFY 2022 Net Income: -$170K2022FY 2023 Revenue: $598KFY 2023 Net Income: -$252K2023FY 2024 Revenue: $1.84MFY 2024 Net Income: $87K2024FY 2025 Revenue: $5.69MFY 2025 Net Income: $642K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31
Revenue $5.69M $1.84M $598K $69K $0 $0 $0
Cost of Revenue $2.45M $536K $113K $9.7K -- -- --
Gross Profit $3.24M $1.31M $484K $60K -- -- --
Research & Development $38K $26K $0 -- -- -- --
Selling, General & Admin $2.21M $1.15M $706K $151K $92K $26K $7.7K
Total Operating Expenses $2.52M $1.22M $736K $230K $92K $26K $7.7K
Operating Income $719K $87K -$252K -$170K -$92K -$26K -$7.7K
Interest Expense -- -- -- -- -- $450 --
Income Before Tax -- -- -- -- -$83K -$26K --
Income Tax Expense $77K $0 $0 $0 $0 $0 $0
Net Income $642K $87K -$252K -$170K -$83K -$26K -$7.7K
Basic EPS $0.23 $0.04 -$0.04 -- -- $0.00 $0.00
Diluted EPS $0.23 $0.04 -$0.04 -- -- $0.00 $0.00
Basic Shares Outstanding 2.8M 2.7M 8.7M -- -- 1.4M 975.4K
Diluted Shares Outstanding 2.9M 2.8M 8.7M -- -- 1.4M 975.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $970K $1.04M $751K $1.57M $1.13M $1.76M $1.23M $610K
Cost of Revenue $333K $377K $265K $1.00M $433K $683K $331K $271K
Gross Profit $638K $659K $486K $572K $698K $1.07M $896K $339K
Research & Development $60K $71K $50K -$29K $20K $9.2K $38K -$3.9K
Selling, General & Admin -- -- $626K $656K $577K $540K $434K $300K
Total Operating Expenses $786K $877K $716K $729K $707K $617K $469K $329K
Operating Income -$148K -$218K -$230K -$157K -$8.8K $458K $427K $10.0K
Interest Expense $965 -- -- -- $0 -- -- --
Income Tax Expense $0 -$32K -- -- $0 $0 -- --
Net Income -$149K -$186K -$230K -$234K -$8.8K $458K $427K $10.0K
Basic EPS -$0.01 -$0.02 -$0.08 -- $0.00 $0.04 $0.04 --
Diluted EPS -$0.01 -$0.02 -$0.08 -- $0.00 $0.04 $0.04 --
Basic Shares Outstanding 11.8M 11.7M 2.9M -- 11.0M 11.0M 11.3M --
Diluted Shares Outstanding 11.8M 11.7M 2.9M -- 11.0M 11.4M 11.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31
Cash & Cash Equivalents $662K $663K $19K $12K $16K $2.0K $21K $0
Cash & Short-Term Investments $662K $663K $19K $12K $16K $2.0K $21K $0
Accounts Receivable, Net $399K $100K $36K $7.8K -- -- -- --
Inventory $336K $58K $38K $12K -- -- -- --
Total Current Assets $1.56M $848K $93K $32K $16K $6.3K $21K --
Intangible Assets $83K $26K $0 -- -- -- -- --
Total Non-Current Assets $149K $26K $0 $0 $0 $0 $0 --
Total Assets $1.71M $874K $93K $32K $16K $6.3K $21K $1.9K
Accounts Payable $6.3K $8.2K $7.7K $3.4K $1.9K $0 $760 $0
Deferred Revenue (Current) $137K $24K $3.9K $0 -- -- -- --
Other Current Liabilities -- -- -- -- -- $0 -- --
Total Liabilities $230K $39K $100K $49K $1.9K $19K $7.8K $0
Common Stock $1.1K $4.4K $4.1K $546 $546 $546 $546 $280
Retained Earnings $301K -$341K -$428K -$177K -$117K -$34K -$8.6K -$900
Total Stockholders' Equity $1.48M $835K -$6.8K -$17K $14K -$13K $13K $1.9K
Total Equity $1.48M $835K -$6.8K -$17K $14K -$13K $13K $1.9K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $1.69M $712K $1.15M $662K $1.14M $1.30M $1.03M $663K
Cash & Short-Term Investments $1.69M $712K $1.15M $662K $1.14M $1.30M $1.03M $663K
Accounts Receivable, Net $478K $397K $78K $399K $63K $390K $93K $100K
Inventory $711K $797K $874K $336K $758K $249K $216K $58K
Total Current Assets $3.01M $1.99M $2.19M $1.56M $1.99M $1.99M $1.34M $848K
Intangible Assets $170K $110K $83K $83K $72K $72K $56K $26K
Total Non-Current Assets $197K $149K $135K $149K $72K $72K $56K $26K
Total Assets $3.20M $2.14M $2.33M $1.71M $2.07M $2.06M $1.39M $874K
Accounts Payable $39K $9.7K $6.8K $6.3K $10K $17K $16K $8.2K
Deferred Revenue (Current) $1.5K $2.5K $77K $137K $111K $249K $50K $24K
Total Liabilities $282K $301K $646K $230K $356K $338K $133K $39K
Common Stock $1.2K $1.2K $1.1K $1.1K $1.1K $4.4K $4.4K $4.4K
Retained Earnings -$264K -$115K $71K $301K $535K $543K $86K -$341K
Total Stockholders' Equity $2.92M $1.83M $1.68M $1.48M $1.71M $1.72M $1.26M $835K
Total Equity $2.92M $1.83M $1.68M $1.48M $1.71M $1.72M $1.26M $835K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31
Net Income $642K $87K -$252K -$170K -$83K -$26K -$7.7K
Stock-Based Compensation -- -- $0 $225 -- -- --
Change in Receivables -$299K -$64K -$29K -$7.8K -- -- --
Change in Inventory -$278K -$21K -$25K -$12K -- -- --
Change in Payables -$2.0K $551 -$7.6K $0 $1.9K $0 --
Operating Cash Flow $172K $23K -$308K -$183K -$86K -$29K -$7.7K
Investing Cash Flow -$57K -$26K $0 $0 -- -- $0
Common Stock Issued $0 $755K $265K $150K -- $0 $27K
Financing Cash Flow -$116K $646K $316K $194K $100K $11K $28K
Net Change in Cash -$592 $643K $7.7K $11K $14K -$19K $21K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$149K -$186K -$230K -$234K -$8.8K $458K $427K $10.0K
Change in Receivables -$81K -$319K $321K -$336K $327K -$297K $6.8K -$68K
Change in Inventory $128K $81K -$538K $421K -$509K -$33K -$157K -$16K
Change in Payables -- -- -- -$3.9K -$6.5K $221 $8.2K -$221
Operating Cash Flow -$151K -$542K -$552K -$101K -$340K $285K $328K -$50K
Investing Cash Flow -$60K -$27K $0 -$11K $0 -$16K -$30K -$19K
Common Stock Issued $1.24M $336K $437K $0 $0 $0 $0 $455K
Financing Cash Flow $1.19M $136K $1.04M -$366K $180K $2.1K $68K $399K
Net Change in Cash $979K -$433K $483K -$477K -$160K $271K $366K $329K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31
Gross Margin 57.0% 70.9% 81.1% 86.0% -- -- --
Operating Margin 12.6% 4.7% -42.1% -245.8% -- -- --
Net Profit Margin 11.3% 4.7% -42.1% -245.8% -- -- --
Return on Equity (ROE) 43.5% 10.4% -- -- -578.1% -- -59.9%
Return on Assets (ROA) 37.6% 10.0% -269.3% -539.3% -512.0% -405.6% -37.2%
Revenue Growth (YoY) +208.3% +208.7% +761.8% -- -- -- --
Gross Profit Growth (YoY) +147.6% +170.2% +712.2% -- -- -- --
Operating Income Growth (YoY) +726.5% -- -- -- -- -- --
Net Income Growth (YoY) +638.0% -- -- -- -- -- --
EPS Growth (YoY) +500.0% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) +642.5% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 54.4% 53.8% 54.3% 57.0% 63.6% 65.6% 70.5% 70.9%
Operating Margin -17.4% -13.7% 1.2% 12.6% 18.7% 22.8% 20.3% 4.7%
Net Profit Margin -18.4% -14.7% -0.3% 11.3% 18.7% 22.8% 20.3% 4.7%
Return on Equity (ROE) -27.3% -35.9% -0.9% 43.5% 51.8% 55.3% 44.9% 10.4%
Return on Assets (ROA) -24.9% -30.8% -0.6% 37.6% 42.8% 46.2% 40.7% 10.0%
Revenue Growth (YoY) -14.3% -41.0% -38.8% +157.7% +97.5% +357.5% +342.0% +101.0%
Gross Profit Growth (YoY) -8.7% -38.6% -45.8% +68.7% +64.4% +246.2% +281.7% +43.3%
Operating Income Growth (YoY) -- -147.6% -153.9% -1673.5% -115.6% +516.7% -- --
Net Income Growth (YoY) -- -140.6% -153.9% -2446.4% -115.6% +516.7% -- --
EPS Growth (YoY) -- -150.0% -300.0% -- -100.0% -- -- --
Operating Cash Flow Growth (YoY) -- -290.1% -268.2% -- -751.8% +311.3% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001784440) · from August 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal